Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats

Journal of Oral and Facial Pain and Headache

Volumn 24, Issue 2, 2010, Pages 203-211

  Yang, Gwi Y ^a   Woo, Young W ^a   Park, Min Kyoung ^a   Bae, Yong C ^a   Ahn, Dong K ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Antinociception; Formalin; NMDA; NR2 receptor; Orofacial pain

Indexed keywords

3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; 5,7 DICHLOROKYNURENIC ACID; 5,7-DICHLOROKYNURENIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; FORMALDEHYDE; KYNURENIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENOL DERIVATIVE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CHEMICALLY INDUCED DISORDER; CISTERNA MAGNA; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FACE PAIN; INJECTION; MALE; MOTOR ACTIVITY; NOCICEPTIVE RECEPTOR; PRURITUS; RAT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYNAPTIC TRANSMISSION; TIME; VIBRISSA;

ANIMALS; BEHAVIOR, ANIMAL; CISTERNA MAGNA; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; FACIAL PAIN; FORMALDEHYDE; INJECTIONS; INJECTIONS, SUBCUTANEOUS; KYNURENIC ACID; MALE; MEMANTINE; MOTOR ACTIVITY; NOCICEPTORS; PHENOLS; PIPERAZINES; PIPERIDINES; PRURITUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; TIME FACTORS; VIBRISSAE;

EID: 77954892647     PISSN: 23330384     EISSN: 23330376     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61
2. Paoletti P, Neyton J. NMDA receptor subunits: Function and pharmacology. Curr Opin Pharmacol 2007;7:39-47
3. Childers WE Jr, Baudy RB. N-methyl-D-aspartate antagonists and neuropathic pain: The search for relief. J Med Chem 2007;50:2557-2562
4. McBain CJ, Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 1994;74:723-760
5. Mori H, Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995;34:1219-1237
6. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005;179:4-129
7. Yamakura T, Shimoji K. Subunit-and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 1999;59:279-298
8. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: Diversity, development and disease. Curr Opin Neurobiol 2001;11:327-335
9. Gaunitz C, Schüttler A, Gillen C, Allgaier C. Formalininduced changes of NMDA receptor subunit expression in the spinal cord of the rat. Amino Acids 2002;23:177-182
10. Malmberg AB, Gilbert H, McCabe RT, Basbaum AI. Powerful antinociceptive effects of the cone snail venomderived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 2003;101:109-116
11. Bernardi M, Bertolini A, Szczawinska K, Genedani S. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice. Eur J Pharmacol 1996;298:51-55
12. Taniguchi K, Shinjo K, Mizutani M, et al. Antinociceptive activity of CP-101, 606, an NMDA receptor NR2B subunit antagonist. Br J Pharmacol 1997;122:809-812
13. Boyce S, Wyatt A, Webb JK, et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 1999;38:611-623
14. Liu XJ, Gingrich JR, Vargas-Caballero M, et al. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat Med 2008;14:1325-1332
15. Lee J, Ro JY. Differential regulation of glutamate receptors in trigeminal ganglia following masseter inflammation. Neurosci Lett 2007;421:91-95
16. Dong XD, Mann MK, Kumar U, et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience 2007; 146:822-832
17. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-1036
18. Wang XM, Zhang ZJ, Bains R, Mokha SS. Effect of antisense knock-down of alpha(2a)-and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Pain 2002;98:27-35
19. Ahn DK, Choi HS, Yeo SP, et al. Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception. Pain 2007;132: 23-32
20. Lee MK, Choi BY, Yang GY, et al. Low doses of cannabinoids enhance the antinociceptive effects of intracisternally administered mGluRs groups II and III agonists in formalin-induced TMJ nociception in rats. Pain 2008;139: 367-375
21. Clavelou P, Pajot J, Dallel R, Raboisson P. Application of the formalin test to the study of orofacial pain in the rat. Neurosci Lett 1989;103:349-353
22. Gilbert SD, Clark TM, Flores CM. Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 2001;89:159-165
23. Choi HS, Ju JS, Lee HJ, et al. Effects of TNF-alpha injected intracisternally on the nociceptive jaw-opening reflex and orofacial formalin test in freely moving rats. Prog Neuropsychopharmacol Biol Psychiatry 2003;27: 613-618
24. Choi HS, Ju JS, Lee HJ, Kim BC, Park JS, Ahn DK. Effects of intracisternal injection of interleukin-6 on nociceptive jaw opening reflex and orofacial formalin test in freely moving rats. Brain Res Bull 2003;59:365-370
25. Lee HJ, Choi HS, Jung CY, et al. Intracisternal NMDA produces analgesia in the orofacial formalin test of freely moving rats. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:497-503
26. Peng HY, Chang HM, Chang SY, et al. Orexin-A modulates glutamatergic NMDA-dependent spinal reflex potentiation via inhibition of NR2B subunit. Am J Physiol Endocrinol Metab 2008;295:117-129
27. Gabra BH, Kessler FK, Ritter JK, Dewey WL, Smith FL. Decrease in N-methyl-D-aspartic acid receptor-NR2B subunit levels by intrathecal short-hairpin RNA blocks group I metabotropic glutamate receptor-mediated hyperalgesia. J Pharmacol Exp Ther 2007;322:186-194
28. Christoph T, Reissmüller E, Schiene K, Englberger W, Chizh BA. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: Possible peripheral mechanisms. Brain Red 2005;1048:218-227
29. Berrino L, Oliva P, Massimo F, et al. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur J Pain 2003; 7:131-137
30. Ahn DK, Lim EJ, Kim BC, et al. Compression of the trigeminal ganglion produces prolonged nociceptive behavior in rats. Eur J Pain 2009;13:568-575
31. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesth Analg 2003;97:1108-1116
32. Davies SN, Lodge D. Evidence for involvement of Nmethylaspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res 1987;424: 402-406
33. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987;26:1235-1238
34. Fisher K, Coderre TJ, Hagen NA. Targeting N-methyl-Daspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 2000; 20:358-373
35. Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 2000;16:S73-S79
36. Chiang CY, Park SJ, Kwan CL, Hu JW, Sessle BJ. NMDA receptor mechanisms contribute to neuroplasticity induced in caudalis nociceptive neurons by tooth pulp stimulation. J Neurophysiol 1998;80:2621-2631
37. Luccarini P, Sessle BJ, Woda A. Superficial and deep convergent nociceptive neurons are differentially affected by N-methyl-D-aspartate applied on the brainstem surface of the rat medullary dorsal horn. Neuroscience 2001;107: 311-316
38. Park SJ, Chiang CY, Hu JW, Sessle BJ. Neuroplasticity induced by tooth pulp stimulation in trigeminal subnucleus oralis involves NMDA receptor mechanisms. J Neurophysiol 2001;85:1836-1846
39. Cairns BE, Sessle BJ, Hu JW. Temporomandibular-evoked jaw muscle reflex: Role of brain stem NMDA and non-NMDA receptors. Neuroreport 2001;12:1875-1878
40. Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 2009;459: 703-707
41. Momiyama A. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord. J Physiol 2000;523:621-628
42. Karlsson U, Sjödin J, Angeby Möller K, Johansson S, Wikström L, Nasström J. Glutamate-induced currents reveal three functionally distinct NMDA receptor populations in rat dorsal horn: Effects of peripheral nerve lesion and inflammation. Neuroscience 2002;112:861-868
43. Liaw WJ, Zhu XG, Yaster M, Johns RA, Gauda EB, Tao YX. Distinct expression of synaptic NR2A and NR2B in the central nervous system and impaired morphine tolerance and physical dependence in mice deficient in post-synaptic density-93 protein. Mol Pain 2008;4:45
44. Ultenius C, Linderoth B, Meyerson BA, Wallin J. Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 2006;399:85-90
45. Petrenko AB, Yamakura T, Baba H, Sakimura K. Unaltered pain-related behavior in mice lacking NMDA receptor GluR epsilon 1 subunit. Neurosci Res 2003;46:199-204
46. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997;386:721-724
47. Ma QP, Hargreaves RJ. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 2000;101:699-707
48. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics: Focus on the NR2B subtype. Trends Pharmacol Sci 2001;22:636-642
49. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002;5:1039-1042
50. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain: Multiple drug targets and multiple uses. Curr Pharm Des 2005;11:2977-2994
51. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325:529-531
52. Cai SX. Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds. Curr Top Med Chem 2006;6:651-662
53. Quartaroli M, Fasdelli N, Bettelini L, Maraia G, Corsi M. GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice. Eur J Pharmacol 2001;430:219-227
54. Quartaroli M, Carignani C, Dal Forno G, et al. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. J Pharmacol Exp Ther 1999;290:158-169